10x Genomics Inc - Ordinary Shares - Class A
TXG
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.27B
Close$
$15.08
72.9% downside
Current Fair Value
72.9% downsideOvervalued by 72.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.27 Billion |
|---|---|
| Enterprise Value | $7.87 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.35 |
| Beta | 2.04 |
| Outstanding Shares | 129,984,169 |
Return
| Return on Equity | -9.10% |
|---|---|
| Return on Assets | -7.29% |
| Return on Invested Capital | -9.60% |
Valuation & Multiples
| P/E Ratio | -110.37 |
|---|---|
| PEG | 72.65 |
| Price to Sales | 13.91 |
| Price to Book Ratio | 9.27 |
| Enterprise Value to Revenue | 12.75 |
| Enterprise Value to EBIT | -89.94 |
| Enterprise Value to Net Income | -105 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$146.67 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$147.21 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1653▲ 10.23% |
|---|---|
| Total Calls | 613,600▼ 41.22% |
| Total Puts | 101,400▲ 54.34% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 100.71%▲ 2.19% |
|---|---|
| Total Invested | $4.94B▲ 86.09% |
| Investors Holding | 391▲ 52.00% |
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov